Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_assertion description "[These regions harbor established oncogenes and tumor suppressors, including CCND1 (cyclin D1), MET (hepatocyte growth factor receptor), CDKN2A (cyclin-dependent kinase inhibitor 2A) and CDKN2B (cyclin-dependent kinase inhibitor 2B), as well as many other genes not previously reported to be involved in liver carcinogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_assertion evidence source_evidence_literature NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_assertion SIO_000772 23505090 NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_assertion wasDerivedFrom befree-20150227 NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_assertion wasGeneratedBy ECO_0000203 NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP554508.RAVA6FobbPs5wMbxI6vQahmou_O9ETEn4Y0Y1V7LZncHE130_provenance.